Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
80
TVTX Quote, Financials, Valuation and Earnings
Last price:
$40.3200
Seasonality move
:
33.23%
Day range:
$36.0100 - $42.1300
52-week range:
$12.9100 - $37.5000
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.36x
P/B ratio:
43.01x
Volume:
933K
Avg. volume:
1.6M
1-year change:
135.14%
Market cap:
$3.2B
Revenue:
$233.2M
EPS (TTM):
-$1.08
Earnings Data
Next earnings date for TVTX
Feb 19
2026
Most recent earnings per share
$0.25
Beat by $0.34
(Oct 30/2025)
Consensus Estimate
-$0.09
(Oct 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TVTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/19/2026 | Q4 | $142.2M | -- | -- | $0.22 | -- |
| 10/30/2025 | Q3 | $106.1M | $164.9M | $0.25 | -$0.09 | $0.34 |
| 08/06/2025 | Q2 | $100.2M | $114.4M | -$0.14 | $0.04 | -$0.18 |
| 05/01/2025 | Q1 | $76.9M | $81.7M | -$0.47 | -$0.39 | -$0.07 |
| 02/20/2025 | Q4 | $72.4M | $74.8M | -$0.73 | -$0.38 | -$0.35 |
| 10/31/2024 | Q3 | $60.8M | $62.9M | -$0.70 | -$0.54 | -$0.17 |
| 08/01/2024 | Q2 | $52.7M | $54.1M | -$0.91 | -$0.72 | -$0.19 |
| 05/06/2024 | Q1 | $43.6M | $41.4M | -$1.76 | -$0.79 | -$0.97 |
| 02/15/2024 | Q4 | $41.8M | $45.1M | -$1.18 | -$0.92 | -$0.26 |
| 11/07/2023 | Q3 | -- | $37.1M | -$0.99 | -- | -- |
| 08/03/2023 | Q2 | -- | $59.7M | -$1.13 | -- | -- |
| 05/04/2023 | Q1 | -- | $30.9M | -$1.27 | -- | -- |
| 02/23/2023 | Q4 | -- | $29.3M | -$1.03 | -- | -- |
| 10/27/2022 | Q3 | -- | $28.1M | -$1.09 | -- | -- |
| 08/04/2022 | Q2 | -- | $54.2M | -$1.05 | -- | -- |
| 05/05/2022 | Q1 | -- | $48.5M | -$1.20 | -- | -- |
| 02/24/2022 | Q4 | -- | $57.2M | -$0.84 | -- | -- |
| 10/28/2021 | Q3 | -- | $68.2M | -$0.59 | -- | -- |
| 07/29/2021 | Q2 | -- | $54.6M | -$0.64 | -- | -- |
| 05/06/2021 | Q1 | -- | $47.4M | -$0.96 | -- | -- |
| 03/01/2021 | Q4 | -- | $51M | -$2.37 | -- | -- |
| 11/05/2020 | Q3 | -- | $51.1M | -$0.44 | -- | -- |
| 07/30/2020 | Q2 | -- | $48.4M | -$0.58 | -- | -- |
| 05/11/2020 | Q1 | -- | $47.8M | $0.02 | -- | -- |
| 02/24/2020 | Q4 | -- | $46.7M | -$0.70 | -- | -- |
| 10/30/2019 | Q3 | -- | $44.4M | -$0.85 | -- | -- |
| 08/06/2019 | Q2 | -- | $44.7M | -$0.92 | -- | -- |
| 05/07/2019 | Q1 | -- | $39.6M | -$0.99 | -- | -- |
| 02/26/2019 | Q4 | -- | $43.8M | -$0.18 | -- | -- |
| 11/01/2018 | Q3 | -- | $40.7M | -$1.34 | -- | -- |
| 07/26/2018 | Q2 | -- | $41.3M | -$0.56 | -- | -- |
| 05/01/2018 | Q1 | -- | $38.4M | -$0.46 | -- | -- |
| 02/27/2018 | Q4 | -- | $42.2M | -$0.45 | -- | -- |
| 11/07/2017 | Q3 | -- | $40.3M | -$0.46 | -- | -- |
| 08/09/2017 | Q2 | -- | $38.8M | -$0.34 | -- | -- |
| 05/04/2017 | Q1 | -- | $33.6M | -$0.32 | -- | -- |
| 03/01/2017 | Q4 | -- | $37.3M | -$0.26 | -- | -- |
| 11/03/2016 | Q3 | -- | $33.9M | -$1.00 | -- | -- |
| 08/04/2016 | Q2 | -- | $33.3M | -$0.37 | -- | -- |
| 03/31/2016 | Q1 | -- | $29M | -$0.08 | -- | -- |
| 12/31/2015 | Q4 | -- | $30.4M | -$0.07 | -- | -- |
Travere Therapeutics, Inc. Earnings Questions
-
How Much did Travere Therapeutics, Inc. Generate in Revenue Last Quarter?
Travere Therapeutics, Inc. reported $164.9M worth of top line sales in its most recent quarter.
-
Did Travere Therapeutics, Inc. Beat Earnings Last Quarter?
Travere Therapeutics, Inc. announced earnings per share of $0.25 which represents a beat of analyst forecast a -$0.09 per share.
-
Is Travere Therapeutics, Inc. Profitable?
Travere Therapeutics, Inc. reported $147.5M that represents $1.44 per share over the last quarter.
-
What is the Analyst Consensus for Travere Therapeutics, Inc. EPS Next Year?
Travere Therapeutics, Inc.'s earnings are forecast to decrease from -$4.08 per share to -$2.84 per share next year representing a decrease of -96.72%.
-
When is Travere Therapeutics, Inc.'s Earnings Date?
Travere Therapeutics, Inc.'s next earnings date is February 19, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
